Prolactin-producing pituitary gland carcinoma
disease diseaseOn this page
Also known as malignant pituitary gland prolactinomamalignant pituitary prolactinomamalignant prolactin producing neoplasm of pituitarymalignant prolactin producing neoplasm of pituitary glandmalignant prolactin producing neoplasm of the pituitarymalignant prolactin producing neoplasm of the pituitary glandmalignant prolactin producing pituitary gland neoplasmmalignant prolactin producing pituitary gland tumormalignant prolactin producing pituitary gland tumourmalignant prolactin producing pituitary neoplasmmalignant prolactin producing pituitary tumormalignant prolactin producing pituitary tumourmalignant prolactin producing tumormalignant prolactin producing tumor of pituitarymalignant prolactin producing tumor of pituitary glandmalignant prolactin producing tumor of the pituitarymalignant prolactin producing tumor of the pituitary glandmalignant prolactin producing tumourmalignant prolactin producing tumour of pituitarymalignant prolactin producing tumour of pituitary gland
Summary
Prolactin-producing pituitary gland carcinoma (MONDO:0006388) is a cancer. A subtype of prolactin producing pituitary tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | prolactin-producing pituitary gland carcinoma |
| Mondo ID | MONDO:0006388 |
| EFO | EFO:1000497 |
| NCIT | C5962 |
| UMLS | C1334614 |
| MedGen | 277338 |
| GARD | 0024393 |
| Is cancer (heuristic) | yes |
Also known as: malignant pituitary gland prolactinoma · malignant pituitary prolactinoma · malignant prolactin producing neoplasm of pituitary · malignant prolactin producing neoplasm of pituitary gland · malignant prolactin producing neoplasm of the pituitary · malignant prolactin producing neoplasm of the pituitary gland · malignant prolactin producing pituitary gland neoplasm · malignant prolactin producing pituitary gland tumor · malignant prolactin producing pituitary gland tumour · malignant prolactin producing pituitary neoplasm · malignant prolactin producing pituitary tumor · malignant prolactin producing pituitary tumour · malignant prolactin producing tumor · malignant prolactin producing tumor of pituitary · malignant prolactin producing tumor of pituitary gland · malignant prolactin producing tumor of the pituitary · malignant prolactin producing tumor of the pituitary gland · malignant prolactin producing tumour · malignant prolactin producing tumour of pituitary · malignant prolactin producing tumour of pituitary gland (+28 more)
Disease family
This is a subtype of prolactin producing pituitary tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › endocrine gland neoplasm › pituitary tumor › prolactin producing pituitary tumor › prolactin-producing pituitary gland carcinoma
Related subtypes (1): prolactin-producing pituitary gland adenoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.